NCT03645993 (TGen) is a clinical trial of Genetic Testing in Alzheimer Disease, sponsored by Baylor Research Institute.

Who is sponsoring NCT03645993?

NCT03645993 is sponsored by Baylor Research Institute.

What drugs are being tested in NCT03645993?

Interventions in NCT03645993: Genetic Testing.

What condition does NCT03645993 study?

NCT03645993 studies Alzheimer Disease.

Is NCT03645993 still recruiting?

NCT03645993 is currently completed. Last updated 12 February 2026.

Last reviewed 2026-02-12 · How we verify

NCT03645993: TGen

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Early Onset Alzheimer's Disease Genomic Study

Completed Last updated 12 February 2026

What this trial tests

trial testing Genetic Testing in Alzheimer Disease in 26 participants. Completed in 24 April 2024.

Timeline

16 June 2017

Primary endpoint
24 April 2024

24 April 2024

Quick facts

Lead sponsor	Baylor Research Institute
Status	Completed
Study type	OBSERVATIONAL
Enrollment	26
Start date	16 June 2017
Primary completion	24 April 2024
Estimated completion	24 April 2024
Sites	1 location across United States

Drugs / interventions tested

Genetic Testing

Conditions studied

Alzheimer Disease — all drugs for Alzheimer Disease →

Sponsor

Baylor Research Institute

Who can join

Adults 40 to 65, any sex, with Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to collect samples from patients with Early-Onset Alzheimer's disease (AD) and their immediate family members for molecular analysis. Samples will be studied in order to understand how molecular changes in the body are related to the development of the disease. Researchers will study your DNA and RNA in order to help doctors diagnose, treat, and monitor people at risk of developing Early-Onset AD in the future.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Genetic Testing

Trials testing the same drug.

NCT07377006 — Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer · NA · not yet recruiting
NCT07091617 — Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer · NA · recruiting
NCT07143487 — Family Communications After Genetic Testing · NA · not yet recruiting
NCT03897374 — Strategic Targeting for Optimal Prevention of Cancer · recruiting
NCT06794567 — Genomic First Testing in Chronic Kidney Disease · not yet recruiting

Other recruiting trials for Alzheimer Disease

Currently open trials in the same condition.

NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
NCT07178210 — Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease · NA · recruiting
NCT07294885 — Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease · NA · recruiting
NCT06937229 — A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms · NA · recruiting

Other Baylor Research Institute trials

Trials by the same sponsor.

NCT07467720 — Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial · NA · not yet recruiting
NCT07547878 — Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) · Phase 4 · not yet recruiting
NCT07460583 — ProActive Athlete Heart Program: Proposal for Cardiac Risk Screening in Former High-Intensity Athletes · NA · not yet recruiting
NCT07096544 — CALM Study: Cardiomems Assisted Lvad Management · NA · not yet recruiting
NCT07220395 — eHealth Literacy Intervention for Spanish Speaking Older Adults in the US · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03645993 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baylor Research Institute
Last refreshed: 12 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03645993.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing